Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report

Overview of attention for article published in Frontiers in Neurology, September 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 7 X posts from 5 X users, with an upper bound of 11,752 followers.

RT @hopebio_org: HOT OFF THE PRESS!!! Wondering what led to us conducting 4 clinical trials for Parkinson's Disease? Every story has a begi…

Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report https://t.co/6lxJauUJA7 #Parkinson #neurologia

RT @FrontNeurol: New Research: Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's di…

🙌🙌🙌

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.